Enteral nutrition is also known as tube feeding and is used when a patient is unable to eat and must be given nutrition in an alternative manner. Tube feeding delivers the required nutritional supplements directly into the stomach of the patient. Infant feeding deals with the delivery of nutrition into the stomach of new born babies. Parenteral nutrition is a method of delivering nutrition into the body through the veins. Parenteral nutrition provides essential nutrients to patients of cancer, short bowel syndrome, and ischemic bowel disease.
The global clinical nutrition market is estimated to account for US$ 48.6 Bn in terms of value in 2020 and is expected to reach US$ 66.2 Bn by the end of 2027.
Global Clinical Nutrition Market: Drivers
Increasing number of children suffering from malnutrition is expected to propel growth of the global clinical nutrition market over the forecast period. For instance, according to the World Health Organization, in 2018, globally there were 149 million children under 5 year of age were stunted, 49 million wasted, and 40 million overweight.
Global Clinical Nutrition Market: Opportunities
Development of amino acids solution that contains a more substantial amount of essential amino acids such as cysteine and tyrosine is expected to improve parenteral nutrition. This in turn is expected to offer lucrative growth opportunities for players in the market.
Global Clinical Nutrition Market: Restraints
Increasing prevalence of food allergies in infants and young children is expected to hinder growth of the market. For instance, according to the study, “A cross-sectional study of the prevalence of food allergies among children younger than ages 14 years in a Beijing urban region”, published in the journal Allergy & Asthma Proceedings, in January 2019, the total prevalence of probable food allergies in children aged less than 14 years of age in the Beijing urban area was 3.2%.
Milk based nutrition segment was valued at US$ 9.9 Bn in 2019 and is forecast to reach a value of US$ 13.8 Bn by 2027 at a CAGR of 4.2%. Milk based nutrition offers clinical benefits associated with the milk such as protein, vitamins, and minerals which is expected to support growth of the segment.
Infant nutrition held dominant position in the global clinical nutrition market in 2019, accounting for 56.0% share in terms of value, followed by enteral nutrition and parenteral nutrition, respectively. Increasing product launches is expected to support growth of the segment. For instance, in 2017, Abbott added a new ingredient –2’-fucosyllactose— found in human breast milk to its Similac Pro-advance and Pro Sensitive infant formulas and linked to demonstrate its benefits for babies via boosting their immune system.
In China, it is mandatory for manufacturers of clinical nutrition products to re-register the baby formulas with the government.
Major players in the market are focused on R&D of new products. For instance, in March 2020, Novo Nordisk announced that Saxenda (liraglutide 3.0 mg), a once-daily glucagon-like peptide-1 (GLP-1) analogue, demonstrated positive results in adolescents with obesity.
Global Clinical Nutrition Market: Competitive Landscape
Major players operating in the global clinical nutrition market include, Baxter International, Inc., Abbott Laboratories, B. Braun Melsungen AG, H. J. Heinz Company, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, Hospira, Inc., and Perrigo Company Plc.
Global Clinical Nutrition Market: Key Developments
March 2020: Bayer collaborated with Direct Relief and Feeding America to donate one million products that including over-the-counter medications and multivitamins to ease the burden COVID-19 on healthcare systems